How was SCI Pharmtech's revenue in March 2026?

It was TWD 128 million, a sharp decline of 24.4% year-over-year.

What kind of company is SCI Pharmtech?

It is a company that develops and manufactures active pharmaceutical ingredients (APIs) for pharmaceutical companies.

Why did SCI Pharmtech's revenue decrease significantly?

The likely reasons include a temporary decrease in orders from its pharmaceutical clients or a lack of shipments for certain products.

AI News NQ Analysis

【SCI Pharmtech】March 2026 Revenue NT$128 Million (YoY -24.4%)

NQ Score 4/100

N1 Content Completeness 5

AI Summary (NQ-processed)

SCI Pharmtech's revenue for March 2026 was NT$128 million, a decrease of 24.4% year-over-year. The company is in the Biotechnology and Medical Care industry.

AI Analysis

Frequently Asked Questions

Q: How was SCI Pharmtech's revenue in March 2026?: A: It was TWD 128 million, a sharp decline of 24.4% year-over-year.
Q: What kind of company is SCI Pharmtech?: A: It is a company that develops and manufactures active pharmaceutical ingredients (APIs) for pharmaceutical companies.
Q: Why did SCI Pharmtech's revenue decrease significantly?: A: The likely reasons include a temporary decrease in orders from its pharmaceutical clients or a lack of shipments for certain products.